Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Novela italiana
7
Operas
5
Historia
3
Cirugía
2
Cuentos chinos
2
Extractos
2
Oratorios (Música)
2
Robótica
2
Agrobiodiversidad
1
Análisis modal
1
Architectural design
1
Architectural rendering
1
Arroz híbrido
1
Arte chino
1
Arte mexicano
1
Artes Marciales
1
Atlas
1
Ave María (Música)
1
Biotecnología
1
Biotecnología agrícola
1
Boánica
1
Canciones infantiles
1
Canciones sacras
1
Canciones sacras (Voces agudas) y orquesta
1
Cantatas
1
Cartografía
1
Cibernética
1
Cirugía ortopédica
1
Comercio
1
Comunismo
1
-
55681por Armoiry, Xavier, Sturt, Jackie, Phelps, Emma Elizabeth, Walker, Clare-Louise, Court, Rachel, Taggart, Frances, Sutcliffe, Paul, Griffiths, Frances, Atherton, Helen“…ID=CRD 42016 035467(Archived by WebCite at http://www.webcitation.org/6vpgZU1FU)…”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
55682por Grace, Rebekah, Kemp, Lynn, Barnes, Jacqueline, Elcombe, Emma, Knight, Jennifer, Baird, Kelly, Webster, Vana, Byrne, Fiona“…id=370304 (Archived by WebCite athttp://www.webcitation.org/70q42fU7V) REGISTERED REPORT IDENTIFIER: RR1-10.2196/1000…”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
55683por Shortridge, Dee, McCurdy, Sandra P, Rhomberg, Paul R, Huband, Michael D, Flamm, Robert K“…All of the subjects had a favorable microbiological response (presumed eradication) at FU. CONCLUSION: DLX demonstrated potent in vitro antibacterial activity against anaerobic isolates tested, including BF and CP and was more active than MXF. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
55684por Höglander, Elen Kristine, Nord, Silje, Wedge, David C., Lingjærde, Ole Christian, Silwal-Pandit, Laxmi, Gythfeldt, Hedda vdL, Vollan, Hans Kristian Moen, Fleischer, Thomas, Krohn, Marit, Schlitchting, Ellen, Borgen, Elin, Garred, Øystein, Holmen, Marit M., Wist, Erik, Naume, Bjørn, Van Loo, Peter, Børresen-Dale, Anne-Lise, Engebraaten, Olav, Kristensen, Vessela“…METHODS: A phase II randomized clinical trial of 123 patients with Her2-negative breast cancer was conducted, with patients treated with neoadjuvant chemotherapy (fluorouracil (5FU)/epirubicin/cyclophosphamide (FEC) and taxane), with or without bevacizumab. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
55685por Xu, Di, Chen, Xiu, Li, Xingjiang, Mao, Zhixiang, Tang, Wenjuan, Zhang, Wei, Ding, Li, Tang, Jinhai“…Objective: Capecitabine is an antimetabolic fluoropyrimidine deoxynucleoside carbamate drug that can be converted to 5-FU in vivo. Currently, the role of capecitabine in the treatment of advanced breast cancer has been recognized. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
55686por Smeland, Hilde Ytre-Hauge, Lu, Ning, Karlsen, Tine V., Salvesen, Gerd, Reed, Rolf K., Stuhr, Linda“…PIF was measured by the wick-in-needle technique, collagen by Picrosirius Red staining and electron microscopy, and uptake of radioactively labeled 5FU by microdialysis. Further, PIF in heterospheroids composed of MDA-MB-231 cells and wild type or integrin α11-deficient fibroblasts was measured by micropuncture. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
55687por Hu, J. L., Wang, W., Lan, X. L., Zeng, Z. C., Liang, Y. S., Yan, Y. R., Song, F. Y., Wang, F. F., Zhu, X. H., Liao, W. J., Liao, W. T., Ding, Y. Q., Liang, L.“…Mechanically, increased expression of miR-92a-3p activates Wnt/β-catenin pathway and inhibits mitochondrial apoptosis by directly inhibiting FBXW7 and MOAP1, contributing to cell stemness, EMT, metastasis and 5-FU/L-OHP resistance in CRC. Clinically, miR-92a-3p expression is significantly increased in CRC tissues and negatively correlated with the levels of FBXW7 and MOAP1 in CRC specimens, and high expression of exosomal miR-92a-3p in serum was highly linked with metastasis and chemotherapy resistance in CRC patients. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
55688por Scholl, Suzy, Popovic, Marina, de la Rochefordiere, Anne, Girard, Elodie, Dureau, Sylvain, Mandic, Aljosa, Koprivsek, Katarina, Samet, Nina, Craina, Marius, Margan, Madalin, Samuels, Sanne, Zijlmans, Henry, Kenter, Gemma, Hillemanns, Peter, Dema, Sorin, Dema, Alis, Malenkovic, Goran, Djuran, Branislav, Floquet, Anne, Garbay, Delphine, Guyon, Frédéric, Colombo, Pierre Emmanuel, Fabbro, Michel, Kerr, Christine, Ngo, Charlotte, Lecuru, Fabrice, Campo, Eleonor Rivin del, Coutant, Charles, Marchal, Frédéric, Mesgouez-Nebout, Nathalie, Fourchotte, Virginie, Feron, Jean Guillaume, Morice, Philippe, Deutsch, Eric, Wimberger, Pauline, Classe, Jean-Marc, Gleeson, Noreen, von der Leyen, Heiko, Minsat, Mathieu, Dubot, Coraline, Gestraud, Pierre, Kereszt, Attila, Nagy, Istvan, Balint, Balazs, Berns, Els, Jordanova, Ekaterina, Saint-Jorre, Nicolas de, Savignoni, Alexia, Servant, Nicolas, Hupe, Philippe, de Koning, Leanne, Fumoleau, Pierre, Rouzier, Roman, Kamal, Maud“…FINDINGS: At a median follow up (FU) of 22 months, progression-free survival rates of this FIGO stage IB1-IV population, treated predominantly (87%) by chemoradiation, were65•4% [CI95%: 60•2-71.1]. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
55689por Tan, Eberta, Khoo, Joan, Gani, Linsey Utami, Malakar, Roy Debajyoti, Tay, Tunn Lin, Tirukonda, Prasanna Sivanath, Kam, Jia Wen, Tin, Aung Soe, Tang, Tjun Yip“…Patients in the routine clinical care arm will receive standard clinical care. Follow up (FU) will be for 3 years. Primary outcomes include cardiovascular events, rate of progression of nephropathy and development of end-stage renal disease. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
55690por Nowland, Samantha J., Silva, Catarina N. S., Southgate, Paul C., Strugnell, Jan M.“…Mitochondrial COI analyses also revealed a ‘star-like’ haplotype network, and significant and negative neutrality tests (Tajima’s D = − 2.030, Fu’s Fs = − 25.638, P < 0.001) support a recent population expansion after a bottleneck. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
55691por Cai, Rui, Wang, Ping, Zhao, Xin, Lu, Xiansheng, Deng, Ruxia, Wang, Xiaoyu, Su, Zhaoji, Hong, Chang, Lin, Jie“…We further found that down-regulation of LTBP1 enhanced ESCC cells’ sensitivity to 5-FU treatment. Inhibition of LTBP1 expression could also attenuate induction of CAFs transformation and restrain fibroblast express fibronectin (FN1) in ESCC cells. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
55692“…Nine received Natto 2,000 FU daily and eight received an identical placebo capsule daily. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
55693“…The preferred concurrent chemotherapy regimen was 5-FU/Mitomycin C, whereas 6 (6%) prescribed Capecitabine/Mitomycin C. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
55694por Zantop, Thore, Zantop, Christian, Hönninger, Anja, Hauner, Dominik, Warminski, Przemyslaw, Angele, Peter“…CONCLUSION: This prospective analysis of patients following cartilage regeneration implicates that the use of a multifactorial “return-to-sports” analysis 12 months postoperatively provides a good correlation to the clinical outcome and scores. At this FU point, Patients following MACT show knee joint function that is close to normal.…”
Publicado 2020
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
55695por Tintelnot, Joseph, Goekkurt, Eray, Binder, Mascha, Thuss-Patience, Peter, Lorenzen, Sylvie, Knorrenschild, Jorge Riera, Kretzschmar, Albrecht, Ettrich, Thomas, Lindig, Udo, Jacobasch, Lutz, Pink, Daniel, Al-Batran, Salah-Eddin, Hinke, Axel, Hegewisch-Becker, Susanna, Nilsson, Sven, Bokemeyer, Carsten, Stein, Alexander“…METHODS: The INTEGA study is an open-label, randomized, multicenter, exploratory phase II trial designed to assess clinical performance, safety and tolerability of ipilimumab or 5-FU/folinic acid and oxaliplatin (FOLFOX) in combination with nivolumab and trastuzumab in patients with previously untreated HER2-positive, locally advanced or metastatic EGA. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
55696por Sui, Hua, Zhang, Lu, Gu, Kaijuan, Chai, Ni, Ji, Qing, Zhou, Lihong, Wang, Yan, Ren, Junze, Yang, Limei, Zhang, Bimeng, Hu, Jing, Li, Qi“…METHODS: Here, we used C57BL/6 J Apc(Min/+) mice, an animal model of human intestinal tumorigenesis, to investigate the gut bacterial diversity and their mechanisms of action in gastrointestinal adenomas, and to evaluate the effects of Yi-Yi-Fu-Zi-Bai-Jiang-San (YYFZBJS) on of colon carcinogenesis in vivo and in vitro. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
55697por de Souza, Fabricio, Lanzendorf, Felipe Nunes, de Souza, Márcia Mendonça Marcos, Schuelter-Trevisol, Fabiana, Trevisol, Daisson José“…Four studies reported Tai Chi practice, one study reported Kung Fu exercise, and another study reported martial arts exercise. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
55698por Tenuta, Marta, Tarsitano, Maria G., Mazzotta, Paola, Lucchini, Livia, Sesti, Franz, Fattorini, Giorgio, Pozza, Carlotta, Olivieri, Valerio, Naro, Fabio, Gianfrilli, Daniele, Lenzi, Andrea, Isidori, Andrea M., Pofi, Riccardo“…Afterward, nine patients continued therapy for 3 more months (PT group) and 15 discontinued (FU group). A 4‐month evaluation (V(2)) was performed in both groups. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
55699por Ricco, Anthony, Barbera, Gabrielle, Lanciano, Rachelle, Feng, Jing, Hanlon, Alexandra, Lozano, Alicia, Good, Michael, Arrigo, Stephen, Lamond, John, Yang, Jun“…Multivariable analysis (MVA) was accomplished with a backwards selection Cox proportional-hazards model with statistical significance taken at the p < 0.05 level. Results: Median FU is 78.4 months. Five- and ten-year OS KM estimates are 90.9 and 73.2%, respectively, with 19 deaths recorded. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
55700por Vignolini, Graziano, Greco, Isabella, Sessa, Francesco, Gemma, Luca, Pecoraro, Alessio, Barzaghi, Paolo, Grosso, Antonio, Corti, Francesco, Mormile, Nicola, Martiriggiano, Marco, Berni, Alessandro, Firenzuoli, Niccolò, Gacci, Mauro, Giancane, Saverio, Sebastianelli, Arcangelo, Li Marzi, Vincenzo, Serni, Sergio, Campi, Riccardo“…Overall, 7/39 (18%) patients (all recipients from DDs) experienced DGF; two of them were on dialysis at last FU. Conclusions: Our experience confirms the feasibility, safety, and favorable mid-term outcomes of RAKT from both LDs and DDs in appropriately selected recipients, highlighting the opportunity to tailor the technique to specific recipient- and/or graft-characteristics. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto